Dose Rationale for Favipiravir Use in Patients Infected With SARS-CoV-2.

Eloy, Philippine; Solas, Caroline; Touret, Franck; Mentré, France; Malvy, Denis; de Lamballerie, Xavier; Guedj, Jérémie

Eloy, Philippine; Solas, Caroline; Touret, Franck; Mentré, France; Malvy, Denis; de Lamballerie, Xavier; Guedj, Jérémie.

Eloy P; Département d'Epidémiologie, Biostatistiques et Recherche Clinique, Hôpital Bichat-Claude Bernard, AP-HP.Nord Université de Paris, Paris, France.
Solas C; Institut National de la Santé et de la Recherche Médicale (INSERM), CIC-EC 1425, Hôpital Bichat-Claude Bernard, Paris, France.
Touret F; APHM, Unité des Virus Émergents (UVE: IRD 190-Inserm 1207-IHU Méditerranée Infection), Laboratoire de Pharmacocinétique et Toxicologie, Hôpital La Timone, Aix Marseille University, Marseille, France.
Mentré F; Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France.
Malvy D; IAME, Inserm, University of Paris, Paris, France.
de Lamballerie X; Department for Infectious and Tropical Diseases, University Hospital Center of Bordeaux, Bordeaux, France.
Guedj J; Inserm 1219, University of Bordeaux, Bordeaux, France.

Clin Pharmacol Ther ; 108(2): 188, 2020 08.

Article in English | MEDLINE | ID: covidwho-154959

Subject(s)

Coronavirus Infections; Pandemics; Pneumonia, Viral; Severe acute respiratory syndrome-related coronavirus; Amides; Betacoronavirus; COVID-19; Humans; Pyrazines; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Severe acute respiratory syndrome-related coronavirus / Pandemics Limits: Humans Language: English Journal: Clin Pharmacol Ther Year: 2020 Document Type: Article Affiliation country: Cpt.1877

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google